c0NAXfIdXhsrYYfCVfBlZc4ckp0oAVyDzUP5Cv0IU61WnwyTiDczu0TY0YKF
Current position: Home >> Scientific Research >> Paper Publications

Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia

Hits:

Institution:药学院

Title of Paper:Simultaneous inhibition of FLT3 and HDAC by novel 6-ethylpyrazine-2-Carboxamide derivatives provides therapeutic advantages in acute myelocytic leukemia

Journal:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

First Author:Chang, Yingjie

Document Code:1843556249584635906

Volume:279

Issue:279

Number of Words:9

Translation or Not:No

Date of Publication:2024-12

Release Time:2025-02-13

Prev One:五育融合视域下药学专业实验教学体系建设实践

Next One:Development of a First-in-Class DNMT1/HDAC Inhibitor with Improved Therapeutic Potential and Potentiated Antitumor Immunity